In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 Christian Hamm
Speaker
Christian Hamm
Christian Hamm Christian Hamm

Kerckhoff Clinic, Bad Nauheim (Germany)

Specialities : Interventional Cardiology , Acute Coronary Syndromes, Interventional Cardiology, Valvular Heart Disease

Professor Christian Hamm received his medical training at the Universities of Mainz and Hamburg before undertaking research fellowships at the Ischaemic Heart Research Unit, University of Cape Town and in the Department of Cardiology at the University of Hamburg. He accepted the position of Associate Professor in Internal Medicine and Cardiology at the University Hospital in Hamburg in 1989, before becoming Medical Director and Chief of Cardiology at the Kerckhoff Heart and Thorax Center, Bad Nauheim, Germany, in 1999. Since 2013 he is also full Professor of Cardiology and Director of the Medical Clinic I at the University of Giessen, Germany. His major research interests include acute coronary syndrome, cardiac biomarkers, cardiac MRI and CT, and interventional cardiology. He has been the principle investigator for many national and international multicenter clinical trials and is member of several ESC guideline committees. He serves in the Editorial Boards of many renowned journals.

21 presentations from this speaker

Measurement of troponins (before and) after coronary revascularization: meaningless?

Event : ESC Congress 2019

  • Session : Expert Advice - Not all myocardial infarctions are created equal
  • Speaker : C Hamm (Bad Nauheim,DE)

Discussant review - High-STEACS.

Event : ESC Congress 2018

  • Session : Hot Line Session 5
  • Speaker : C Hamm (Bad Nauheim,DE)

Registry and survey information from Germany: problems and opportunities in improving care for valvular heart disease.

Event : ESC Congress 2018

  • Session : Valvular heart disease - The "Big Picture"
  • Speaker : C Hamm (Bad Nauheim,DE)
  • Organised with the German Cardiac Society

Troponin elevation post noncardiac surgery - Conclusion and take home message

Event : ESC Congress 2018

  • Session : Myocardial injury versus myocardial infarction - Implications for clinical practice
  • Speaker : C Hamm (Bad Nauheim,DE)

Coronary aneurysms and ectasia.

Event : ESC Congress 2017

  • Session : Unusual coronary pathology: what to do
  • Speaker : C Hamm (Bad Nauheim,DE)

Discussion - Optimising antiplatelet therapy from first medical contact to discharge.

Event : ESC Congress 2016

  • Session : The clinical journey after an acute coronary syndrome: strategies for optimising antiplatelet therapy
  • Speaker : D Capodanno (Catania,IT), C Hamm (Bad Nauheim,DE), S James (Uppsala,SE), P Steg (Paris,FR), M Bonaca (Boston,US)
  • Organised by University Hospital, Umeå / Course Director: Prof Ulf Näslund / Supported by an unrestricted educational grant from AstraZeneca

Discussion - The patient journey after an acute coronary syndrome - A clinical case study.

Event : ESC Congress 2016

  • Session : The clinical journey after an acute coronary syndrome: strategies for optimising antiplatelet therapy
  • Speaker : D Capodanno (Catania,IT), C Hamm (Bad Nauheim,DE), S James (Uppsala,SE), P Steg (Paris,FR), M Bonaca (Boston,US)
  • Organised by University Hospital, Umeå / Course Director: Prof Ulf Näslund / Supported by an unrestricted educational grant from AstraZeneca

Discussion - Who, when and why - The rationale to treat beyond 12 months.

Event : ESC Congress 2016

  • Session : The clinical journey after an acute coronary syndrome: strategies for optimising antiplatelet therapy
  • Speaker : D Capodanno (Catania,IT), C Hamm (Bad Nauheim,DE), S James (Uppsala,SE), P Steg (Paris,FR), M Bonaca (Boston,US)
  • Organised by University Hospital, Umeå / Course Director: Prof Ulf Näslund / Supported by an unrestricted educational grant from AstraZeneca

Insights from National registries

Event : ESC Congress 2016

  • Session : Update on transcatheter aortic valve implantation in 2016
  • Speaker : C Hamm (Bad Nauheim,DE)

Summary and close - The clinical journey after an acute coronary syndrome: strategies for optimising antiplatelet therapy.

Event : ESC Congress 2016

  • Session : The clinical journey after an acute coronary syndrome: strategies for optimising antiplatelet therapy
  • Speaker : C Hamm (Bad Nauheim,DE)
  • Organised by University Hospital, Umeå / Course Director: Prof Ulf Näslund / Supported by an unrestricted educational grant from AstraZeneca

Troponin elevation (mis)guidance? - Conclusion and take home message

Event : ESC Congress 2016

  • Session : 2015 NSTE - Acute coronary syndromes Guidelines in daily practice
  • Speaker : C Hamm (Bad Nauheim,DE)

A case of severe angina non suitable for revascularisation - Conclusion and take home message.

Event : ESC Congress 2015

  • Session : Are clinical guidelines the standard of care in real practice?
  • Speaker : C Hamm (Bad Nauheim,DE)

Clinical case study – Optimal duration of dual antiplatelet therapy.

Event : ESC Congress 2015

  • Session : Dual anti-platelet therapy in atherothrombosis in 2015: debating the evidence
  • Speaker : C Hamm (Bad Nauheim,DE)
  • Organised by University Hospital of Umea Course Director: Ulf Naslund Supported by an unrestricted educational grant from AstraZeneca

Discussion - Dual anti-platelet therapy in atherothrombosis in 2015: debating the evidence.

Event : ESC Congress 2015

  • Session : Dual anti-platelet therapy in atherothrombosis in 2015: debating the evidence
  • Speaker : K Fox (Edinburgh,GB), C Hamm (Bad Nauheim,DE), M Sabatine (Boston,US), N Danchin (Montreuil,FR)
  • Organised by University Hospital of Umea Course Director: Ulf Naslund Supported by an unrestricted educational grant from AstraZeneca

Open questions - Dual anti-platelet therapy in atherothrombosis in 2015: debating the evidence.

Event : ESC Congress 2015

  • Session : Dual anti-platelet therapy in atherothrombosis in 2015: debating the evidence
  • Speaker : K Fox (Edinburgh,GB), C Hamm (Bad Nauheim,DE)
  • Organised by University Hospital of Umea Course Director: Ulf Naslund Supported by an unrestricted educational grant from AstraZeneca

Should the same rules apply for drug and device approval? EU - Physicians.

Event : ESC Congress 2015

  • Session : Should the same rules apply for drug and device approval? EU vs. US perspective
  • Speaker : C Hamm (Bad Nauheim,DE)

Summary and close - Dual anti-platelet therapy in atherothrombosis in 2015: debating the evidence.

Event : ESC Congress 2015

  • Session : Dual anti-platelet therapy in atherothrombosis in 2015: debating the evidence
  • Speaker : C Hamm (Bad Nauheim,DE)
  • Organised by University Hospital of Umea Course Director: Ulf Naslund Supported by an unrestricted educational grant from AstraZeneca

German Aortic Valve Registry: differential 1 year outcome in TAVI procedures

Event : ESC Congress 2014

  • Session : Registry Hot Line: Valves and heart failure
  • Speaker : C Hamm (Bad Nauheim,DE)

CHAMPION: Cangrelor for Percutaneous Coronary Intervention

Event : ESC Congress 2013

  • Session : Clinical Trial Update Hot Line II: Updates on intervention and devices
  • Speaker : C Hamm (Bad Nauheim,DE)

Key clinical decisions in patients with acute coronary syndromes.

Event : ESC Congress 2013

  • Session : Clinical crossroads in thrombosis: stroke prevention in AF; secondary prevention in ACS
  • Speaker : C Hamm (Bad Nauheim,DE)
  • Sponsored by theheart.org / Medscape Education

Which antiplatelet therapy for which patient?

Event : ESC Congress 2013

  • Session : Underutilisation of novel antiplatelet agents. What went wrong?
  • Speaker : C Hamm (Bad Nauheim,DE)

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are